ID

17908

Beschreibung

Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00509600

Link

https://clinicaltrials.gov/show/NCT00509600

Stichworte

Versionen (1)
  1. 07.10.16 07.10.16 -
Hochgeladen am

7. Oktober 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Leukemia NCT00509600

Englisch

Eligibility Leukemia NCT00509600

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00509600
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. all children greater than 6 months of age and less than 18 years of age with newly-diagnosed previously untreated or previously diagnosed jmml, which has reoccurred after treatment with chemotherapy, stem cell transplantation, and/or cis-retinoic acid.
Beschreibung

Child | Age | Juvenile Myelomonocytic Leukemia | Chemotherapy | Stem cell transplant | Isotretinoin | Recurrent disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0008059
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0349639
UMLS CUI [4]
C0392920
UMLS CUI [5]
C1504389
UMLS CUI [6]
C0022265
UMLS CUI [7]
C0277556
2. a diagnosis of jmml is confirmed only if the following criteria for jmml are met: a) all of the following: absence of t(9;22) or bcr-abl by pcr or fish; absolute monocyte count >1000 (1 x 109/µl); <20% bone marrow blasts; b) at least 2 of the following: elevated hb f hemoglobin; myeloid precursors in peripheral blood; wbc >10,000 (10 x 109/µl); gm-csf hypersensitivity in methylcellulose culture of bone marrow progenitors cells.
Beschreibung

Juvenile Myelomonocytic Leukemia | t(9;22) Absence | BCR-ABL Fusion Gene Absence | Polymerase Chain Reaction | Fluorescent in Situ Hybridization | Absolute monocyte count increased | Blasts Bone marrow Percentage | Fetal Hemoglobin Elevated | leukocyte morphology myeloid precursors peripheral blood | White Blood Cell Count procedure | Hypersensitivity Granulocyte-Macrophage Colony-Stimulating Factor | Methylcellulose | Bone Marrow Stem cells

Datentyp

boolean

Alias
UMLS CUI [1]
C0349639
UMLS CUI [2,1]
C3897138
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1835417
UMLS CUI [3,2]
C0332197
UMLS CUI [4]
C0032520
UMLS CUI [5]
C0162789
UMLS CUI [6]
C1698571
UMLS CUI [7,1]
C1982687
UMLS CUI [7,2]
C0439165
UMLS CUI [8,1]
C0015936
UMLS CUI [8,2]
C3163633
UMLS CUI [9,1]
C2168792
UMLS CUI [9,2]
C0229664
UMLS CUI [10]
C0023508
UMLS CUI [11,1]
C0020517
UMLS CUI [11,2]
C0079460
UMLS CUI [12]
C0025729
UMLS CUI [13,1]
C0005953
UMLS CUI [13,2]
C0038250
3. adequate hepatic function (bilirubin equal or less than 2.0 mg/dl; alt equal or less than 3x normal)
Beschreibung

Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
4. adequate renal function (serum creatinine equal or less than 2 x normal)
Beschreibung

Renal function | Creatinine measurement, serum

Datentyp

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
5. performance status: have a karnofsky score >50.
Beschreibung

Karnofsky Performance Status

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
6. written, informed consent according to institution guidelines.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. pregnant or lactating.
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
2. receiving any other chemotherapy. patients must have been off chemotherapy for at least 2 weeks and must have recovered from acute toxicity of all previous therapy prior to enrollment.
Beschreibung

Chemotherapy Discontinued | Toxic effect Due to Prior Therapy | Patient Recovered

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1444662
UMLS CUI [2,1]
C0600688
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C1514463
UMLS CUI [3,1]
C0030705
UMLS CUI [3,2]
C0521108
3. febrile neutropenia at study entry.
Beschreibung

Febrile Neutropenia

Datentyp

boolean

Alias
UMLS CUI [1]
C0746883
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Leukemia NCT00509600

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00509600
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Child | Age | Juvenile Myelomonocytic Leukemia | Chemotherapy | Stem cell transplant | Isotretinoin | Recurrent disease
Item
1. all children greater than 6 months of age and less than 18 years of age with newly-diagnosed previously untreated or previously diagnosed jmml, which has reoccurred after treatment with chemotherapy, stem cell transplantation, and/or cis-retinoic acid.
boolean
C0008059 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0349639 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C1504389 (UMLS CUI [5])
C0022265 (UMLS CUI [6])
C0277556 (UMLS CUI [7])
Juvenile Myelomonocytic Leukemia | t(9;22) Absence | BCR-ABL Fusion Gene Absence | Polymerase Chain Reaction | Fluorescent in Situ Hybridization | Absolute monocyte count increased | Blasts Bone marrow Percentage | Fetal Hemoglobin Elevated | leukocyte morphology myeloid precursors peripheral blood | White Blood Cell Count procedure | Hypersensitivity Granulocyte-Macrophage Colony-Stimulating Factor | Methylcellulose | Bone Marrow Stem cells
Item
2. a diagnosis of jmml is confirmed only if the following criteria for jmml are met: a) all of the following: absence of t(9;22) or bcr-abl by pcr or fish; absolute monocyte count >1000 (1 x 109/µl); <20% bone marrow blasts; b) at least 2 of the following: elevated hb f hemoglobin; myeloid precursors in peripheral blood; wbc >10,000 (10 x 109/µl); gm-csf hypersensitivity in methylcellulose culture of bone marrow progenitors cells.
boolean
C0349639 (UMLS CUI [1])
C3897138 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1835417 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0032520 (UMLS CUI [4])
C0162789 (UMLS CUI [5])
C1698571 (UMLS CUI [6])
C1982687 (UMLS CUI [7,1])
C0439165 (UMLS CUI [7,2])
C0015936 (UMLS CUI [8,1])
C3163633 (UMLS CUI [8,2])
C2168792 (UMLS CUI [9,1])
C0229664 (UMLS CUI [9,2])
C0023508 (UMLS CUI [10])
C0020517 (UMLS CUI [11,1])
C0079460 (UMLS CUI [11,2])
C0025729 (UMLS CUI [12])
C0005953 (UMLS CUI [13,1])
C0038250 (UMLS CUI [13,2])
Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement
Item
3. adequate hepatic function (bilirubin equal or less than 2.0 mg/dl; alt equal or less than 3x normal)
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
Renal function | Creatinine measurement, serum
Item
4. adequate renal function (serum creatinine equal or less than 2 x normal)
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Karnofsky Performance Status
Item
5. performance status: have a karnofsky score >50.
boolean
C0206065 (UMLS CUI [1])
Informed Consent
Item
6. written, informed consent according to institution guidelines.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
1. pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Chemotherapy Discontinued | Toxic effect Due to Prior Therapy | Patient Recovered
Item
2. receiving any other chemotherapy. patients must have been off chemotherapy for at least 2 weeks and must have recovered from acute toxicity of all previous therapy prior to enrollment.
boolean
C0392920 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0600688 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C1514463 (UMLS CUI [2,3])
C0030705 (UMLS CUI [3,1])
C0521108 (UMLS CUI [3,2])
Febrile Neutropenia
Item
3. febrile neutropenia at study entry.
boolean
C0746883 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video